These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38241595)

  • 21. Tumorigenic role of Pak4 in ovarian cancer and its correlation with immune infiltration.
    Tang L; Ye H; Chen L; Dong W; Hu X; Yu L
    BMC Med Genomics; 2024 May; 17(1):148. PubMed ID: 38807162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
    Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
    J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 24. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
    Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
    Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of the role of chemokine CX3CL1 (Fractalkine) and CX3C chemokine receptor 1 in systemic sclerosis.
    Pezeshkian F; Shahriarirad R; Mahram H
    Immun Inflamm Dis; 2024 Oct; 12(10):e70034. PubMed ID: 39392260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel immune-related prognostic signature in epithelial ovarian carcinoma.
    Su T; Zhang P; Zhao F; Zhang S
    Aging (Albany NY); 2021 Apr; 13(7):10289-10311. PubMed ID: 33819196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The stromal tumor-infiltrating lymphocytes, cancer stemness, epithelial-mesenchymal transition, and B7-H4 expression in ovarian serous carcinoma.
    Hwang C; Lee HJ; Na JY; Kim KH; Song YJ; Kim JY; Kim K; Shin DH; Park JY; Kim SY; Lee JH; Choi KU
    J Ovarian Res; 2023 Jan; 16(1):3. PubMed ID: 36609273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-omics analysis of tumor mutational burden combined with prognostic assessment in epithelial ovarian cancer based on TCGA database.
    Liu J; Xu W; Li S; Sun R; Cheng W
    Int J Med Sci; 2020; 17(18):3200-3213. PubMed ID: 33173439
    [No Abstract]   [Full Text] [Related]  

  • 30. Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer.
    Liao WT; Chu PY; Su CC; Wu CC; Li CJ
    Pathol Res Pract; 2022 Dec; 240():154215. PubMed ID: 36423401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Expression of
    Zou R; Xu H; Li F; Wang S; Zhu L
    DNA Cell Biol; 2021 Jan; 40(1):36-60. PubMed ID: 33180631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERAP2 Is Associated With Immune Infiltration and Predicts Favorable Prognosis in SqCLC.
    Yang Z; Tian H; Bie F; Xu J; Zhou Z; Yang J; Li R; Peng Y; Bai G; Tian Y; Chen Y; Liu L; Fan T; Xiao C; Zheng Y; Zheng B; Wang J; Li C; Gao S; He J
    Front Immunol; 2021; 12():788985. PubMed ID: 34992605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of
    Jiang S; Yang Y; Zhang Y; Ye Q; Song J; Zheng M; Li X
    Dis Markers; 2022; 2022():9719671. PubMed ID: 35186171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the role of miR-200 family in regulating CX3CR1 and CXCR1 in lung adenocarcinoma tumor microenvironment: implications for therapeutic intervention.
    Sharma A; Singh P; Jha R; Almatroodi SA; Alrumaihi F; Rahmani AH; Alharbi HO; Dohare R; Syed MA
    Sci Rep; 2023 Sep; 13(1):16333. PubMed ID: 37770496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.
    Xu Y; Chen L; Xu B; Xiong Y; Yang M; Rui X; Shi L; Wu C; Jiang J; Lu B
    Cell Physiol Biochem; 2017; 41(2):475-483. PubMed ID: 28214872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased co-expression of MEST and BRCA1 is associated with worse prognosis and immune infiltration in ovarian cancer.
    Zhang J; Yu S; Li Q; Wang Q; Zhang J
    Gynecol Oncol; 2022 Mar; 164(3):566-576. PubMed ID: 35042621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wiskott-Aldrich syndrome gene as a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma.
    Ding G; Wang T; Liu S; Zhou Z; Ma J; Wu J
    Front Immunol; 2023; 14():1102824. PubMed ID: 37122750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of key molecular markers in epithelial ovarian cancer by integrated bioinformatics analysis.
    Qin W; Yuan Q; Liu Y; Zeng Y; Ke D; Dai X; Shuai Y; Hu J; Shi H
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):983-994. PubMed ID: 34794761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the KRT7 Biomarker in Immune Infiltration and Paclitaxel Resistance in Ovarian.
    Wang S; Li H; Li M; Liu X; Yu S; Huang H; Wang X
    Altern Ther Health Med; 2023 Jul; 29(5):132-140. PubMed ID: 37023314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.